Heart failure by British Medical Association

British Medical Association

1. Heart failure: the percentage of patients with a current diagnosis of heart failure due to left ventricular dysfunction (LVD) who are currently treated with angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB), who can tolerate therapy and for whom there is no contraindication. This updates a previously published measure summary.
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14469


2. Heart failure: the percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with ACE inhibitor or ARB, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14470


3. Heart failure: the percentage of patients with a diagnosis of heart failure (diagnosed after 1 April 2006) which has been confirmed by an echocardiogram or by specialist assessment. This updates a previously published measure summary.
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14468


4. Heart failure: the practice can produce a register of patients with heart failure. This updates a previously published measure summary.
http://www.qualitymeasures.ahrq.gov/summary/summary.aspx?ss=1&doc_id=14467

SOURCE(S)
British Medical Association (BMA) and NHS Employers. Quality and outcomes framework guidance for GMS contract 2009/10. London (UK): British Medical Association, National Health Service Confederation; 2009 Mar. 162 p.